Non-opioid Pain Patch Market Trends

  • Report ID: 5423
  • Published Date: Sep 11, 2025
  • Report Format: PDF, PPT

Non-opioid Pain Patch Market Growth Drivers and Challenges:

Growth Drivers

  • Rising Trend of Minimally Invasive Procedures – Non-opioid pain patch are kind of minimally invasive treatments as they aid in administrating non-addictive pain medication by being applied to the skin similar to a bandage.

  • Growing Geriatric Population- Even though there are numerous options for pain alleviation, a large number of older persons choose not to seek therapy and opt for patch such as transdermal patch which are frequently used to address chronic pain in older adults.

  • Lately, more than 8% of the global population, are 65 years of age or older.
  • Non-Opioid Pain Patch for the Treatment of Cancer- If a doctor wants to use fewer opioids’ patients with cancer pain can safely and effectively use a lidocaine or buprenorphine patch for 3-5 days that might be able to help with pain management.

Challenges

  • Presence of Other Pain Management Strategies  - Apart from non-opioid pain patch pain management techniques include at-home therapies such as yoga, psychological therapies including cognitive behavioral therapy, relaxation techniques, and meditation, mind-body techniques, massage therapy, and aqua therapy that can benefit people who suffer from low back pain, migraines, fibromyalgia, arthritis, and other chronic pain as they are simple, accessible, and safe method of managing pain that people can use in a class with an instructor or at home with online videos.

  • There are numerous drugs available to manage pain including acetaminophen a first choice for many types of pain, paracetamol which is advised as the initial medication to treat acute pain, and other medications including aspirin, ibuprofen, and naproxen that are usually used to treat minor to severe pain.

  • Furthermore, the two easiest and least expensive ways to get rid of acute and chronic pain are heat and cold therapy which also help increase blood flow and metabolism.
  • Stringent Rules & Regulations for Product Approval
  • Exorbitant Cost of Pain Patch Resulting from Disruptions in Supply Chain

Base Year

2025

Forecast Period

2026-2035

CAGR

6.4%

Base Year Market Size (2025)

USD 998.64 million

Forecast Year Market Size (2035)

USD 1.86 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of non-opioid pain patch is estimated at USD 1.06 billion.

The global non-opioid pain patch market size crossed USD 998.64 million in 2025 and is likely to expand at a CAGR of over 6.4%, surpassing USD 1.86 billion revenue by 2035.

North America’s non-opioid pain patch market dominates with a 51% share by 2035, driven by the presence of key players leading to the development of new products.

Key players in the market include GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos